Welcome to Servier Indonesia

More information about the Servier group


employees worldwide


countries in which
the Group’s medicines
are distributed


of revenue from
brand-name medicines
invested in R&D each year

€4.9 billion

Euros in revenue in 2021/2022 comprising
€3.7 billion for brand-name medicines and
€1.2 billion for generic medicines.

4 therapeutic areas

Oncology, Neuroscience,
Immuno-inflammation, Cardiometabolism

Servier Medical Art is a medical image bank that we make available to illustrate your medical releases.